MRAP2
Basic information
Region (hg38): 6:84033772-84090881
Previous symbols: [ "C6orf117" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Obesity, susceptibility to, 18 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Endocrine | 23869016 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRAP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 18 | 20 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 3 | 1 | 1 | 5 | ||
non coding | 5 | |||||
Total | 0 | 0 | 22 | 9 | 4 |
Variants in MRAP2
This is a list of pathogenic ClinVar variants found in the MRAP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-84055314-C-T | MRAP2-related disorder | Likely benign (May 02, 2022) | ||
6-84055325-G-A | MRAP2-related disorder | Uncertain significance (Jan 20, 2024) | ||
6-84055336-A-C | MRAP2-related disorder | Uncertain significance (Jul 10, 2024) | ||
6-84055345-C-T | MRAP2-related disorder | Likely benign (Sep 04, 2024) | ||
6-84055346-A-G | Uncertain significance (Jun 01, 2024) | |||
6-84055354-C-A | MRAP2-related disorder | Likely benign (Aug 27, 2023) | ||
6-84055360-A-G | MRAP2-related disorder | Likely benign (Oct 31, 2022) | ||
6-84055362-C-T | not specified | Uncertain significance (Aug 30, 2023) | ||
6-84055376-G-C | not specified • MRAP2-related disorder | Uncertain significance (Sep 22, 2023) | ||
6-84055382-A-G | MRAP2-related disorder | Uncertain significance (Aug 10, 2023) | ||
6-84055387-G-A | MRAP2-related disorder | Uncertain significance (Mar 04, 2024) | ||
6-84055388-G-T | Body mass index quantitative trait locus 18 | risk factor (Jul 19, 2013) | ||
6-84055396-A-G | MRAP2-related disorder | Likely benign (Dec 15, 2023) | ||
6-84055399-T-G | Uncertain significance (May 05, 2023) | |||
6-84055413-C-T | MRAP2-related disorder | Uncertain significance (Aug 10, 2024) | ||
6-84055427-G-A | not specified | Uncertain significance (Jun 17, 2022) | ||
6-84055432-GA-G | MRAP2-related disorder | Uncertain significance (Dec 19, 2023) | ||
6-84055436-G-T | MRAP2-related disorder | Uncertain significance (Apr 30, 2024) | ||
6-84055440-A-C | MRAP2-related disorder | Uncertain significance (Nov 27, 2023) | ||
6-84055450-G-T | MRAP2-related disorder | Uncertain significance (Aug 14, 2023) | ||
6-84055452-T-G | MRAP2-related disorder | Benign (Jan 31, 2024) | ||
6-84055455-A-G | MRAP2-related disorder | Likely benign (Mar 14, 2023) | ||
6-84062885-T-C | MRAP2-related disorder | Uncertain significance (Apr 03, 2024) | ||
6-84062886-C-G | MRAP2-related disorder | Likely benign (Sep 21, 2023) | ||
6-84062888-T-G | MRAP2-related disorder | Likely benign (Sep 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRAP2 | protein_coding | protein_coding | ENST00000257776 | 3 | 57126 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.56e-7 | 0.0906 | 125717 | 0 | 30 | 125747 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.309 | 99 | 108 | 0.916 | 0.00000520 | 1355 |
Missense in Polyphen | 38 | 36.723 | 1.0348 | 490 | ||
Synonymous | -0.249 | 44 | 42.0 | 1.05 | 0.00000221 | 389 |
Loss of Function | -0.670 | 9 | 7.08 | 1.27 | 2.95e-7 | 96 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000490 | 0.000490 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000543 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000198 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Modulator of melanocortin receptor 4 (MC4R), a receptor involved in energy homeostasis. Plays a central role in the control of energy homeostasis and body weight regulation by increasing ligand-sensitivity of MC4R and MC4R-mediated generation of cAMP (By similarity). May also act as a negative regulator of MC2R: competes with MRAP for binding to MC2R and impairs the binding of corticotropin (ACTH) to MC2R. May also regulate activity of other melanocortin receptors (MC1R, MC3R and MC5R); however, additional evidences are required in vivo. {ECO:0000250, ECO:0000269|PubMed:19329486, ECO:0000269|PubMed:20371771}.;
- Disease
- DISEASE: Obesity (OBESITY) [MIM:601665]: A condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. {ECO:0000269|PubMed:23869016}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.352
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 36.86
Haploinsufficiency Scores
- pHI
- 0.184
- hipred
- N
- hipred_score
- 0.334
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.261
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrap2
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype;
Zebrafish Information Network
- Gene name
- mrap2a
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- energy reserve metabolic process;feeding behavior;regulation of signaling receptor activity;protein localization to plasma membrane;energy homeostasis;positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;negative regulation of protein localization to plasma membrane
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane
- Molecular function
- protein binding;receptor regulator activity;corticotropin hormone receptor binding;type 3 melanocortin receptor binding;type 4 melanocortin receptor binding;type 5 melanocortin receptor binding;identical protein binding;type 1 melanocortin receptor binding